Canon Introduces Alphenix 4D CT at ECIO 2025
Vienna, Tuesday, 8 April 2025.
Canon Medical unveils the Alphenix 4D CT, integrating CT, angiography, and ultrasound in one suite, boosting diagnostic precision and workflow efficiency in interventional oncology.
Revolutionary Integration in Medical Imaging
Canon Medical Systems Corporation has unveiled a significant advancement in interventional oncology at ECIO 2025 in Rotterdam. The Alphenix 4D CT system represents a breakthrough in medical imaging technology, combining CT and angiography capabilities with ultrasound functionality in a single interventional suite [1]. This integration enables healthcare providers to conduct diagnosis, treatment, and verification procedures with enhanced precision and efficiency, all within one specialized room [1].
Enhanced Clinical Capabilities
The system’s comprehensive approach to interventional oncology is further augmented by the inclusion of the Aplio i800 ultrasound system, which brings advanced fusion imaging and precise needle guidance capabilities to clinical procedures [1]. Canon Medical, with its century-long commitment to healthcare innovation [3], has developed this solution as part of their broader mission to transform healthcare workflows and improve patient outcomes [1].
Upcoming Expert Symposium
On April 13, 2025, leading interventional oncologists will gather for a symposium titled ‘Superpower for All: The Alphenix 4D CT’ [1][3]. This event will showcase real-world applications and clinical impacts of the technology, providing healthcare professionals with valuable insights into its practical implementation. The symposium, taking place at ECIO 2025, represents a crucial platform for knowledge sharing in the field of interventional oncology [1].
Corporate Commitment to Healthcare Innovation
Canon Medical Systems Corporation, headquartered in Otawara-shi, Tochigi-ken, Japan, continues to demonstrate its commitment to healthcare advancement through this latest innovation [3]. With a workforce of 5,001-10,000 employees, the company maintains its focus on patient-centered digital transformation in healthcare, aiming to enhance both diagnostic accuracy and treatment outcomes [3]. This development aligns with their established philosophy of building long-term relationships based on transparency and trust with medical professionals [3].